Presented by
Dirk Pohlmann

Nominated by

Max-Planck-Innovation

 

Using patented and price winning technology („humanity in science 2015“, “medicine makers power list 2015”) from the Max Planck labs of Potsdam and Magdeburg this company will lower the prices of antimalarials and could achieve a medical breakthrough, providing very good and very low cost anti-cancer medications to developing countries. Artemiflow will produce 2.5 times as much of the best amount anti-malarial medications from the plant Artemisia annua as before – enabling research in collaboration with top scientists which could lead to use of the same compound as a powerful, extreme low cost anti-cancer medication for developing countries.

More Venture Finalists

All Venture Finalists